Fortis Launches Institute of Genomic Medicine to Transform Healthcare

Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle...

Alembic Receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg

Alembic Pharmaceuticals Limited (Alembic) has received from the U.S. Food and Drug Administration (U.S. FDA), final approval for its ANDA application for...

India Revises Pharma Import Monitoring Fees to Boost Compliance

The Foreign Trade Policy (FTP) 2023's Appendix 2K has been updated by the Directorate General of Foreign Trade (DGFT), requiring pharmaceutical imports and exports to pay a registration fee through the Import Monitoring System (IMS). The objective o

Health Ministry limits use of common cold meds for kids below four years

The Union Health Ministry hereby prohibits the use of cold FDC Chlorpheniramine Maleate 2 mg and Phenylephrine Hydrochloride 5 mg per ml drops in children below the...

Venus Remedies' Polymyxin B Gets US FDA QIDP Designation

The United States Food and Drug Administration (US FDA) has designated Venus Remedies Limited, a Panchkula-based pharmaceutical company that specializes in critical care injectables, as a Qualified Infectious Disease Product (QIDP) for the....

India's $10B pharma exports to US face probe amid rising trade tensions

India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation

Medical Device Makers in India Push for Safeguard Duty on Imports

Amidst the ongoing difficulties in global commerce brought on by US-China tariffs, India's medical equipment industry is seeing a startling increase in imports. Citing the possibility of serious harm to the domestic economy, the Association of Indian

Johnson & Johnson warns that pharma tariffs could lead to drug shortages

Johnson & Johnson's CEO has cautioned that any US tariffs on the pharmaceutical sector may result in medication shortages. The Trump administration has made it plain that it is considering utilizing the broad tariffs that were announced this month

Dr. Lal PathLabs Launches South Asia's First Advanced Amyloidosis Test

A pioneer in diagnostic medicine, Dr. Lal PathLabs Limited (Dr. Lal PathLabs) has unveiled Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry, a ground-breaking test for precisely identifying various forms of amyloid....

New ResolverRAT malware targets healthcare & pharma companies globally

The campaign that spreads ResolverRAT through phishing emails uses a remote access trojan and targets the healthcare and pharmaceutical sectors. These emails are written in...

© 2025 India Pharma Outlook. All Rights Reserved.